Doxycycline Formulations for Skin Infections

Efficacy and Recommendations

The Infectious Diseases Society of America recommends doxycycline (both formulations) as an effective treatment option for skin and soft tissue infections (SSTIs), particularly for methicillin-resistant Staphylococcus aureus (MRSA) infections 1, 2, 3
The standard dosage for skin infections is 100 mg twice daily regardless of formulation, as recommended by the Clinical Infectious Diseases guidelines 1, 2, 3
Both formulations have identical antimicrobial activity against common skin pathogens including Staphylococcus aureus and Streptococcus species, according to the World Journal of Emergency Surgery 3, 4

The American Academy of Pediatrics states that doxycycline is contraindicated in children under 8 years of age due to risk of dental staining 1, 5
For skin infections where MRSA is suspected, doxycycline (either formulation) is an appropriate oral option, as recommended by the Clinical Infectious Diseases guidelines 3, 4
When treating streptococcal skin infections, some guidelines recommend combining doxycycline with a beta-lactam antibiotic for more complete coverage, according to the Clinical Infectious Diseases journal 4, 6

The World Journal of Emergency Surgery recommends 7-14 days of therapy for most uncomplicated skin infections 4
The Clinical Infectious Diseases journal states that duration should be based on clinical response, with resolution of erythema, warmth, and induration indicating successful treatment 6